Novel Therapy for Unresectable Hilar Cholangiocarcinoma Ã¢ÂÂKlatskin TumorÃ¢ÂÂ Utilizing Percutaneous Irreversible Electroporation: A Case ReportMazal N1* and West D1,2
- *Corresponding Author:
- Nicolas Mazal
Department of Diagnostic and Interventional Imaging
The University of Texas Health Science Center
E-mail: [email protected]
Received Date: March 28, 2017; Accepted Date: April 06, 2017; Published Date: April 12, 2017
Citation: Mazal N, West D (2017) Novel Therapy for Unresectable Hilar Cholangiocarcinoma ‘Klatskin Tumor’ Utilizing Percutaneous Irreversible Electroporation: A Case Report. OMICS J Radiol 6:258. doi: 10.4172/2167-7964.1000258
Copyright: © 2017 Mazal N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Unresectable hilar cholangiocarcinoma ‘Klatskin Tumor’ is a rare malignancy with limited treatment options and an overall poor prognosis. Percutaneous Irreversible Electroporation (IRE) is a relatively new ablative procedure with potential for treating unresectable cholangiocarcinoma, improving morbidity, and ultimately prolonging survival. The main benefit of IRE relies in the non-thermal technology which can be considered in patients with hilar tumors given the criticality of the adjacent vessels and bile ducts. This case report describes a 71 year old female with unresectable Bismuth-Corlette Stage IV cholangiocarcinoma who underwent IRE with disease control 13 months after treatment.